It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Details
Title
Author Correction: Inhibitory effects of dopamine receptor D1 agonist on mammary tumor and bone metastasis
Author
Minami, Kazumasa 1 ; Liu, Shengzhi 2 ; Liu, Yang 2 ; Chen, Andy 3 ; Wan, Qiaoqiao 4 ; Na, Sungsoo 4 ; Li, Bai-Yan 5 ; Matsuura, Nariaki 6 ; Koizumi, Masahiko 7 ; Yin, Yukun 8 ; Gan, Liangying 8 ; Xu, Aihua 8 ; Li, Jiliang 8 ; Nakshatri, Harikrishna 9 ; Yokota, Hiroki 4
1 Indiana University Purdue University Indianapolis, Department of Biomedical Engineering, Indianapolis, USA (GRID:grid.257413.6) (ISNI:0000 0001 2287 3919); Osaka University Graduate School of Medicine Suita, Department of Medical Physics & Engineering, Osaka, Japan (GRID:grid.136593.b) (ISNI:0000 0004 0373 3971)
2 Indiana University Purdue University Indianapolis, Department of Biomedical Engineering, Indianapolis, USA (GRID:grid.257413.6) (ISNI:0000 0001 2287 3919); Harbin Medical University, Department of Pharmacology, School of Pharmacy, Harbin, China (GRID:grid.410736.7) (ISNI:0000 0001 2204 9268)
3 Purdue University, Weldon School of Biomedical Engineering, West Lafayette, USA (GRID:grid.169077.e) (ISNI:0000 0004 1937 2197)
4 Indiana University Purdue University Indianapolis, Department of Biomedical Engineering, Indianapolis, USA (GRID:grid.257413.6) (ISNI:0000 0001 2287 3919)
5 Harbin Medical University, Department of Pharmacology, School of Pharmacy, Harbin, China (GRID:grid.410736.7) (ISNI:0000 0001 2204 9268)
6 Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan (GRID:grid.416963.f) (ISNI:0000 0004 1793 0765)
7 Osaka University Graduate School of Medicine Suita, Department of Medical Physics & Engineering, Osaka, Japan (GRID:grid.136593.b) (ISNI:0000 0004 0373 3971)
8 Indiana University Purdue University Indianapolis, Department of Biology, Indianapolis, USA (GRID:grid.257413.6) (ISNI:0000 0001 2287 3919)
9 Indiana University School of Medicine, Department of Surgery, Simon Cancer Research Center, Indianapolis, USA (GRID:grid.257413.6) (ISNI:0000 0001 2287 3919)
1 Indiana University Purdue University Indianapolis, Department of Biomedical Engineering, Indianapolis, USA (GRID:grid.257413.6) (ISNI:0000 0001 2287 3919); Osaka University Graduate School of Medicine Suita, Department of Medical Physics & Engineering, Osaka, Japan (GRID:grid.136593.b) (ISNI:0000 0004 0373 3971)
2 Indiana University Purdue University Indianapolis, Department of Biomedical Engineering, Indianapolis, USA (GRID:grid.257413.6) (ISNI:0000 0001 2287 3919); Harbin Medical University, Department of Pharmacology, School of Pharmacy, Harbin, China (GRID:grid.410736.7) (ISNI:0000 0001 2204 9268)
3 Purdue University, Weldon School of Biomedical Engineering, West Lafayette, USA (GRID:grid.169077.e) (ISNI:0000 0004 1937 2197)
4 Indiana University Purdue University Indianapolis, Department of Biomedical Engineering, Indianapolis, USA (GRID:grid.257413.6) (ISNI:0000 0001 2287 3919)
5 Harbin Medical University, Department of Pharmacology, School of Pharmacy, Harbin, China (GRID:grid.410736.7) (ISNI:0000 0001 2204 9268)
6 Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan (GRID:grid.416963.f) (ISNI:0000 0004 1793 0765)
7 Osaka University Graduate School of Medicine Suita, Department of Medical Physics & Engineering, Osaka, Japan (GRID:grid.136593.b) (ISNI:0000 0004 0373 3971)
8 Indiana University Purdue University Indianapolis, Department of Biology, Indianapolis, USA (GRID:grid.257413.6) (ISNI:0000 0001 2287 3919)
9 Indiana University School of Medicine, Department of Surgery, Simon Cancer Research Center, Indianapolis, USA (GRID:grid.257413.6) (ISNI:0000 0001 2287 3919)
Publication year
2022
Publication date
2022
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2737303751
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.